advertisement

---

Chang DS 15

Showing records 1 to 15 | Display all abstracts from Chang DS

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
Friedman DS
Ophthalmology. Glaucoma 2022; 5: 581-586

---

100468 Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes
Chang DS
British Journal of Ophthalmology 2023; 107: 1264-1268

---

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
Chang DS
Ophthalmology. Glaucoma 2022; 5: 581-586

---

100468 Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes
Jiang Y
British Journal of Ophthalmology 2023; 107: 1264-1268

---

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
Jiang Y
Ophthalmology. Glaucoma 2022; 5: 581-586

---

100468 Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes
Kim JA
British Journal of Ophthalmology 2023; 107: 1264-1268

---

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
Huang S
Ophthalmology. Glaucoma 2022; 5: 581-586

---

100468 Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes
Huang S
British Journal of Ophthalmology 2023; 107: 1264-1268

---

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
Kim JA
Ophthalmology. Glaucoma 2022; 5: 581-586

---

100468 Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes
Munoz B; Aung T
British Journal of Ophthalmology 2023; 107: 1264-1268

---

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
Munoz B; Aung T
Ophthalmology. Glaucoma 2022; 5: 581-586

---

100468 Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes
He M; Foster PJ
British Journal of Ophthalmology 2023; 107: 1264-1268

---

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
He M
Ophthalmology. Glaucoma 2022; 5: 581-586

---

100468 Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes
Friedman D
British Journal of Ophthalmology 2023; 107: 1264-1268

---

100595 Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial
Foster PJ
Ophthalmology. Glaucoma 2022; 5: 581-586

---